Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vagus nerve is the tenth cranial nerve (CN X) and is the longest cranial nerve in the body. It contains both sensory (afferent) and motor (efferent) fibers and serves as a major component of the parasympathetic nervous system. It plays a central role in gut-brain communication influencing mood disorders like depression as well as metabolic conditions. Its dysfunction can result in difficulty swallowing or speaking, abnormal heart rate, digestive issues, and may be implicated in inflammatory diseases. Vagus nerve stimulation is used therapeutically for epilepsy treatment and depression management. Drugs like ondansetron act on serotonin receptors located on vagal terminals involved in nausea/vomiting reflexes during chemotherapy-induced emesis.
Vagus nerve stimulation is used therapeutically for epilepsy treatment and depression management. Ondansetron acts on serotonin receptors located on vagal terminals involved in nausea/vomiting reflexes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vagus Nerve.